These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8622777)

  • 1. Clinically meaningful interference in AD progression.
    Phelps CH
    Neurobiol Aging; 1995; 16(6):877-8; discussion 879-82. PubMed ID: 8622777
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of the patient's environment on the progression of Alzheimer's disease.
    Sandman PO
    Neurobiol Aging; 1995; 16(6):871; discussion 879-82. PubMed ID: 8622775
    [No Abstract]   [Full Text] [Related]  

  • 3. A method for estimating progression rates in Alzheimer disease.
    Doody RS; Massman P; Dunn JK
    Arch Neurol; 2001 Mar; 58(3):449-54. PubMed ID: 11255449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AD progression as a function of disease stage.
    Sclan SG
    Neurobiol Aging; 1995; 16(6):865-6; discussion 879-82. PubMed ID: 8622773
    [No Abstract]   [Full Text] [Related]  

  • 5. Methodological aspects of evaluating effects of AD progression.
    Mohs RC
    Neurobiol Aging; 1995; 16(6):867-9; discussion 869-70, 879-82. PubMed ID: 8622774
    [No Abstract]   [Full Text] [Related]  

  • 6. Early psychosocial intervention does not delay institutionalization in persons with mild Alzheimer disease and has impact on neither disease progression nor caregivers' well-being: ALSOVA 3-year follow-up.
    Koivisto AM; Hallikainen I; Välimäki T; Hongisto K; Hiltunen A; Karppi P; Sivenius J; Soininen H; Martikainen J
    Int J Geriatr Psychiatry; 2016 Mar; 31(3):273-83. PubMed ID: 26177825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visit-to-visit blood pressure variability in Alzheimer disease.
    Lattanzi S; Viticchi G; Falsetti L; Buratti L; Luzzi S; Provinciali L; Silvestrini M
    Alzheimer Dis Assoc Disord; 2014; 28(4):347-51. PubMed ID: 24731982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with dementia with lewy bodies have more impaired quality of life than patients with Alzheimer disease.
    Boström F; Jönsson L; Minthon L; Londos E
    Alzheimer Dis Assoc Disord; 2007; 21(2):150-4. PubMed ID: 17545741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A scientific profile for dementia care.
    Wagner L
    Provider; 2000 Nov; 26(11):24-5. PubMed ID: 11185334
    [No Abstract]   [Full Text] [Related]  

  • 10. [Profile of the informal carer associated with the clinical management of the Alzheimer's disease patient refractory to symptomatic treatment of the disease].
    Molinuevo JL; Hernández B;
    Neurologia; 2011 Nov; 26(9):518-27. PubMed ID: 21803459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Less atherosclerosis and lower blood pressure for a meaningful life perspective with more brain.
    Staessen JA; Richart T; Birkenhäger WH
    Hypertension; 2007 Mar; 49(3):389-400. PubMed ID: 17283254
    [No Abstract]   [Full Text] [Related]  

  • 12. The personal and social consequences of Alzheimer disease.
    Coon DW; Edgerly ES
    Genet Test; 1999; 3(1):29-36. PubMed ID: 10464575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.
    Harrington KJ; Ferris RL; Blumenschein G; Colevas AD; Fayette J; Licitra L; Kasper S; Even C; Vokes EE; Worden F; Saba NF; Kiyota N; Haddad R; Tahara M; Grünwald V; Shaw JW; Monga M; Lynch M; Taylor F; DeRosa M; Morrissey L; Cocks K; Gillison ML; Guigay J
    Lancet Oncol; 2017 Aug; 18(8):1104-1115. PubMed ID: 28651929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between changes in quality of life outcomes and progression of Alzheimer's disease: results from the dependence in AD in England 2 longitudinal study.
    Trigg R; Jones RW; Knapp M; King D; Lacey LA;
    Int J Geriatr Psychiatry; 2015 Apr; 30(4):400-8. PubMed ID: 24920081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mastication and oral health-related quality of life in removable denture wearers with Alzheimer disease.
    Campos CH; Ribeiro GR; Rodrigues Garcia RCM
    J Prosthet Dent; 2018 May; 119(5):764-768. PubMed ID: 28967408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Qualifying change: a method for defining clinically meaningful outcomes of change score computation.
    Tractenberg RE; Jin S; Patterson M; Schneider LS; Gamst A; Thomas RG; Thal LJ
    J Am Geriatr Soc; 2000 Nov; 48(11):1478-82. PubMed ID: 11083327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD.
    Tramutola A; Triplett JC; Di Domenico F; Niedowicz DM; Murphy MP; Coccia R; Perluigi M; Butterfield DA
    J Neurochem; 2015 Jun; 133(5):739-49. PubMed ID: 25645581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's disease.
    Yaari R; Corey-Bloom J
    Semin Neurol; 2007 Feb; 27(1):32-41. PubMed ID: 17226739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Social support as a mediator variable of the relationship between depression and life satisfaction in a sample of Saudi caregivers of patients with Alzheimer's disease.
    Khusaifan SJ; El Keshky ME
    Int Psychogeriatr; 2017 Feb; 29(2):239-248. PubMed ID: 27776566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RAPID progression: tool for screening aggressive course of disease (ACD) in Alzheimer dementia.
    Thavichachart N; Worakul P; Farlow MR
    J Med Assoc Thai; 2011 Apr; 94(4):485-9. PubMed ID: 21591535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.